Search

Your search keyword '"Thouvenot, E."' showing total 410 results

Search Constraints

Start Over You searched for: Author "Thouvenot, E." Remove constraint Author: "Thouvenot, E."
410 results on '"Thouvenot, E."'

Search Results

2. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

3. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

4. Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

5. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

7. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

11. Mass cytometry blood immunophenotyping of RRMS patients at diagnosis helps in deciphering subtle changes in myeloid compartment associated to disease evolution

12. Signes et symptômes de la sclérose en plaques

13. Diagnostics différentiels de la sclérose en plaques

14. Thérapeutiques et prise en charge de la sclérose en plaques

15. Diagnostic positif de la sclérose en plaques

16. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.

17. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

18. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

19. Impact of methodological choices in comparative effectiveness studies:application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

20. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

21. Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

23. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France: a pooled analysis from Italy and France

24. Eur J Neurol

25. The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies

26. A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

27. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event

28. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

29. Kappa free light chains is a valid tool in the diagnostics of MS:A large multicenter study

30. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

31. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

34. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions

38. Small obliquely oriented cortical cerebellar infarctions are associated with cardioembolic stroke

39. Kappa free light chains is a valid tool in the diagnostics of MS: a large multicenter study

41. Rivaroxaban for stroke prevention after embolic stroke of undetermined source

43. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

44. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

45. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

46. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

47. Epstein-Barr-negative MS: a true phenomenon?

48. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

49. Comparative hypsometric analysis of both Earth and Venus topographic distributions

50. Neuromyélite optique de Devic et patients à haut risqué : enquête rétrospective nationale

Catalog

Books, media, physical & digital resources